172015-79-1Relevant articles and documents
Abacavir intermediate and method for purifying same
-
, (2018/03/26)
The invention discloses an abacavir intermediate and a method for purifying the same. The method includes heating mixtures with abacavir intermediate crude products, purified water and water-soluble organic solvents until the abacavir intermediate crude products are completely dissolved so as to obtain mixed liquid; carrying out cooling and crystallization treatment on the mixed liquid; carrying out filtering and drying treatment after crystallization treatment is carried out so as to obtain abacavir intermediate pure products. A structural formula of the abacavir intermediate is shown as a formula IV. The abacavir intermediate and the method have the advantage that the method is easy and convenient to implement and is suitable for industrial production.
Process for the preparation of abacavir
-
Page/Page column 5, (2010/11/28)
A process for the preparation of Abacavir of formula 1 and its sulfate salt comprising the reaction of a compound of formula 6 with cyclopropyl amine.
An efficient, scalable synthesis of the HIV reverse transcriptase inhibitor Ziagen (1592U89)
Daluge, Susan M.,Martin, Michael T.,Sickles, Barry R.,Livingston, Douglas A.
, p. 297 - 327 (2007/10/03)
Ziagen, (1S, cis)-4-[2-amino-6-(cyclopropylamino)-9H-purin-9-yl]-2- cyclopentene-1-methanol, was synthesized from (1S,4R)-azabicyclo[2.2.1]hept- 5-en-3-one by efficient processes which bypass problematic steps in earlier routes. 2-Amino-4,6-dichloro-5-formamidopyrimidine is a key intermediate which makes possible an efficient construction of the purine from a chiral cyclopentenyl precursor.